Dr. Yacoub is obtained his medical degree from the University of Jordan, Amman, Jordan, in 2003 and then completed his internship at King Hussein Cancer Center, Amman, Jordan, in 2005. He then moved to the USA where he completed both an internship and his residency in internal medicine at the University of Saint Louis. Dr. […]
Dr. Tsewang Tashi joined the University of Utah faculty after completing his hematology/oncology fellowship in 2015. He received his medical degree from Chang Gung University, Taiwan, and completed his internal medicine residency both in Taiwan, and in the US from Creighton University Medical Center, Omaha, NE. Early in his career during fellowship, he has been […]
Dr. Josef Prchal is a physician scientist. His research focuses on studies of anemias and erythrocytosis, on the molecular and clinical studies of polycythemia vera and essential thrombocythemia, mis-regulated responses to hypoxia including evolutionary Tibetan and other high altitude natives’ adaptation to high altitude. He published 432 peer-reviewed papers and 202 book chapters and reviews. […]
Prof. Lee completed her graduation from the College of Medicine, Hanyang University of Korea in 2003 and later pursued her Ph.D. from The Catholic University of Korea in 2013 for further expertise in the field. She is a well-known Hematologist in Seoul, South Korea with experience of over 17+ years. Her main clinical interests include […]
Dr. Shimoda received his medical degree from the Faculty of Medicine at Kyushu University in Fukuoka, Japan, in 1987, and trained in internal medicine, hematology, and in research in Fukuoka. From 1994 to 1996, he worked as a post-doctoral fellow in Professor Jim Ihle’s Lab, where the vital and essential role of JAK in cytokine […]
Dr. Brandi Reeves is a physician-scientist specializing in myeloproliferative neoplasms (MPN), bone marrow failure syndromes, lower risk myelodysplastic syndromes (MDS), and clonal hematopoiesis. She leads MPN program at University of North Carolina, which was established in 2019 and provides clinical and research expertise for MPN patients. Her research primarily focuses on mechanisms of thrombosis in […]
Dr. Raajit K. Rampal is a hematologist-oncologist who specializes in the treatment of myeloproliferative neoplasms (MPN) and leukemia. Dr. Rampal began his medical career at Stony Brook University, where he earned his MD and PhD in molecular and cellular biology. He went on to complete residency training at the University of Chicago Hospitals, and a […]
Dr. Stephen Oh earned his AB in Biochemical Sciences from Harvard University and his MD/PhD in Cancer Biology from Northwestern University Feinberg School of Medicine, followed by residency, fellowship, and postdoctoral training at Stanford University. Dr. Oh has extensive clinical experience in the diagnosis and management of MPN patients, and have participated in numerous clinical […]
Dr. Ruben Mesa is an international expert in hematologic cancers. He has dedicated his life‘s work to research and drug development for myeloproliferative neoplasms (MPNs). His research focuses on MPN biology, novel therapeutics and over 100 phase I-III clinical trials, symptom assessment tools and non- pharmacological interventions to alleviate MPN symptoms. He has led or […]
Dr. John Mascarenhas is Professor of Medicine at the Icahn School of Medicine at Mount Sinai. He directs the Adult Leukemia Program and leads clinical investigation within the Myeloproliferative Disorders Program. As a clinical investigator in malignant hematology with a focus on translational research involving myeloproliferative neoplasms (MPNs) and evolution to acute myeloid leukemia (AML), […]